Molecular imaging markers in clinical trials in Alzheimer’s disease

被引：0
作者：
A. Nordberg
机构：
[1] Karolinska University Hospital Huddinge,Karolinska Institutet, Department NVS, Division of Alzheimer Neurobiology, Department of Geriatric Medicine
来源：
JNHA - The Journal of Nutrition, Health and Aging | 2009年 / 13卷
关键词：
Mild Cognitive Impairment; Rivastigmine; Mild Cognitive Impairment Patient; Cerebral Glucose Metabolism; Nicotine Binding;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：346 / 347
页数：1
相关论文
共 33 条
[1]  
Nordberg A.(2008)Amyloid Imaging in Alzheimer’s disease Neuropsychologia 46 1636-1641
[2]  
Forsberg A.(2008)N Nordberg A. PET imaging of amyloid deposition in patients with mild cognitive impairment Neurobiology of Aging 20 2007 May 10 [E-pub ahead of print] 29 1456-1465
[3]  
Engler H.(2008)P PET imaging of the in vivo acetylcholinesterase activity and nicotine binding in galantamine-treated patients with Alzheimer’s disease Neurobiology of Aging 28 1201-1217
[4]  
Almkvist O.(2008)Effect of phenserine on brain functional activity and amyloid in AD Ann Neurology 63 621-631
[5]  
Blomquist G.(undefined)undefined undefined undefined undefined-undefined
[6]  
Hagman G.(undefined)undefined undefined undefined undefined-undefined
[7]  
Wall A.(undefined)undefined undefined undefined undefined-undefined
[8]  
Ringheim A.(undefined)undefined undefined undefined undefined-undefined
[9]  
Långström B.(undefined)undefined undefined undefined undefined-undefined
[10]  
Kadir A.(undefined)undefined undefined undefined undefined-undefined
1234